CClinicalTrials.gg
RecruitingNCT07047872Updated Aug 17, 2026

A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction

An interventional study of Computer-Aided Diagnosis and Prosthetics Intervention in Breast Carcinoma, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Nov 2024, registered Jun 2025).
  • Started Nov 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This clinical trial evaluates whether a three-dimensional (3D)-printed external breast prosthesis improves patient-reported outcomes (PRO) among breast cancer patients that underwent surgical removal of the breast (mastectomy) without surgical reconstruction. Breast cancer remains a significant health concern and often requires a mastectomy. While breast reconstruction is a common option following a mastectomy, some patients decide not to undergo it or are not candidates. An external breast prosthesis is worn on the outside of the body to replace the breast that was removed during the mastectomy. Traditional external breast prostheses may lack comfort and fit. A 3D-printed external breast prosthesis is customized to the patient using 3D imaging along with computer-aided design (CAD) to interpret the 3D imaging to develop and print a patient-specific external breast prosthesis. This may create a better fitting prosthesis which may improve PRO.

02

Conditions studied

  • Breast Carcinoma

Browse trials for

03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 50 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult individuals aged 18 years or older
  • History of unilateral or bilateral mastectomy for any indication
  • No implant or autologous reconstruction

    • Allowed: Goldilocks closure, flat closure, simple skin closure
  • Willingness to participate in the study by completing PRO assessments or receiving personalized 3D-printed breast prostheses
  • Ability to provide informed consent
  • Ability to complete study procedures, including surface scanning (with temporary fiducial skin markers), standardized photography, and surveys at 1, 3, 6, and 12 months

Exclusion criteria

Exclusion Criteria:

  • Individuals with contraindications for participation, such as severe medical conditions that may interfere with study procedures
  • Lack of willingness or capacity to provide informed consent for study participation
  • Inability to communicate effectively in the study language (e.g., English)
  • Patients with open wounds, active infection, or dermatologic conditions at the chest/breast site that would interfere with scanning, fiducial marker placement, or prosthesis use
  • Patients unwilling or unable to undergo surface scanning, standardized photography, or complete survey follow-up
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Supportive care (3D-printed external breast prosthesis)

    Patients undergo CT, development of a patient-specific external breast prosthesis model using CAD, and measurements for 3D-printed external breast prosthesis during screening. Patients then undergo fitting for and receive the 3D-printed external breast prosthesis on study.

    Procedure: Computer-Aided Diagnosis · Procedure: Prosthetics Intervention · Other: Questionnaire Administration

Interventions

  • ProcedureComputer-Aided Diagnosis

    Undergo CAD development for patient-specific external breast prosthesis model

    Also known as: CAD

  • ProcedureProsthetics Intervention

    Undergo measurements for external breast prosthesis

  • ProcedureProsthetics Intervention

    Undergo fitting for 3D-printed external breast prosthesis

  • ProcedureProsthetics Intervention

    Receive 3D-printed external breast prosthesis

  • OtherQuestionnaire Administration

    Ancillary studies

06

What researchers measure

Primary outcomes

  1. Patient-reported satisfaction with appearance

    Will be assessed by patient self-reported satisfaction with appearance and evaluated descriptively.

    Time frame: At baseline, 1 month, 3 months, 6 months, and 1 year

  2. Patient-reported emotional well-being

    Will be assessed by a an Emotional Response survey, which consists of 12 questions answered on a five-point Likert scale ranging from strongly disagree to strongly agree.

    Time frame: At baseline, 1 month, 3 months, 6 months, and 1 year

Secondary outcomes

  1. Patient-reported comfort of personalized three-dimensional (3D)-printed breast prosthesis

    Will be assessed by patient response on a 5-point Likert scale ranging from very dissatisfied to very satisfied.

    Time frame: At baseline, 1 month, 3 months, 6 months, and 1 year

  2. Patient-reported fit of personalized 3D-printed breast prosthesis

    Will be assessed by patient response on a 5-point Likert scale ranging from very dissatisfied to very satisfied.

    Time frame: At baseline, 1 month, 3 months, 6 months, and 1 year

  3. Patient-reported satisfaction with personalized 3D-printed breast prosthesis

    Will be assessed by a Prostheses Evaluation survey, which consists of 11 questions answered on a five-point Likert scale ranging from very dissatisfied to very satisfied.

    Time frame: At baseline, 1 month, 3 months, 6 months, and 1 year

07

Study locations

1 of 1 sites recruiting
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
    • Nicole G. Sanchez Figueroa · Contact · sanchezfigueroa.nicole@mayo.edu · 507-538-6419
    • Clinical Trials G. Referral Office, MD, MS · Contact · mayocliniccancerstudies@mayo.edu · 855-776-0015
    • Aparna Vijayasekaran, MBBS · Principal investigator
    • Sandhya Pruthi, MD · Principal investigator
    • Nicole G. Sanchez Figueroa, MD, MS · Sub investigator
    • Amy C. Degnim, MD · Sub investigator
    • Megan L. Loghry · Sub investigator
    • Johnathan M. Morris, MD · Sub investigator
    • Victoria A. Sears, MS · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07047872
Lead sponsor
Mayo Clinic
Responsible party
Sponsor
First posted
Jul 2, 2025
Start date
Nov 5, 2024
Primary completion
Nov 5, 2027 (estimated)
Completion
Nov 5, 2027 (estimated)
Last update
Aug 17, 2026

Study contacts

Aparna Vijayasekaran
Contact
vijayasekaran.aparna@mayo.edu
507-538-1701
Nicole G. Sanchez Figueroa, MD, MS
Contact
sanchezfigueroa.nicole@mayo.edu
507-538-6419
Aparna Vijayasekaran, MBBS
principal investigator · Mayo Clinic
Sandhya Pruthi, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion